Human PUMA shRNA Lentivirus

SKU:BHV19400154
Suppliers
LipExoGen Biotech
LipExoGen Biotech
Details Products
Overview
Click light‑blue chips for details
The Human PUMA shRNA Lentivirus enables stable, high-efficiency knockdown of the pro-apoptotic BH3-only gene BBC3 in human cells. Supplied as high-titer, VSV-G-pseudotyped third-generation particles validated for at least 70% knockdown, it transduces primary and cryopreserved cells and supports stable cell line generation for loss-of-function studies of apoptosis, p53 signaling, tumor suppression, and cancer treatment resistance.
Species Human
Target Gene BBC3
Reporter GFP, RFP, GFP/Luc (+1 more)
Selection Blasticidin, Puromycin
Accession NM_014417.5
Validation ≥70% Knockdown Validated
Format 3rd Gen, VSV-G Pseudotyped
Options selector
Catalog no. Reporter Selection Amount (TU)
LSV-0038-SET1 GFP
LSV-0038-SET2 RFP
LSV-0038-3S GFP/Luc
LSV-0038-4S RFP/Luc
LSV-0038-7S None
Available Options

Select the lentiviral variant that best fits your experiment. Availability and lead time may vary by option.

  • Options:
    • Includes GFP reporter with Puromycin selection; supplied as 5x10^6 (sh-mix) + 5x10^6 (scr-mix) TU.
    • Includes RFP reporter with Blasticidin selection; supplied as 5x10^6 (sh-mix) + 5x10^6 (scr-mix) TU.
    • Includes GFP reporter with Puromycin selection; supplied as 5x10^6 TU.
    • Includes RFP reporter with Blasticidin selection; supplied as 5x10^6 TU.
    • Includes GFP/Luc reporter; supplied as 2x10^6 TU.
    • Includes RFP/Luc reporter; supplied as 2x10^6 TU.
    • Includes GFP reporter with Blasticidin selection; supplied as 5x10^6 TU.
    • Includes RFP reporter with Puromycin selection; supplied as 5x10^6 TU.
    • with Puromycin selection; supplied as 5x10^6 TU.
    • with Blasticidin selection; supplied as 5x10^6 TU.
  • Lead time: typically ships in ~7 business days; timing may vary by selected option.
  • Storage: store at -80°C
  • Shipping: Ships on dry ice
  • Upon receipt: follow the product datasheet storage instructions.
  • Sales terms and conditions: Please review prior to ordering.
Field Specification
Mfr No LSV-0038
Accession Number NM_014417.5
Product Type
  • Lentiviral Vector
  • shRNA Lentivirus
Reporter GFP, RFP, GFP/Luc, RFP/Luc, N/A
Selection Marker Blasticidin, N/A, Puromycin
Shipping Ships on dry ice; store at -80°C
Species Human

Background

PUMA (p53 upregulated modulator of apoptosis), encoded by BBC3, is a BH3-only member of the BCL-2 protein family and a key effector of apoptosis. PUMA expression is induced by p53 following DNA damage and by p53-independent stimuli such as growth factor withdrawal and cellular stress. Once expressed, PUMA binds and inhibits anti-apoptotic BCL-2 proteins, freeing BAX and BAK to permeabilize the mitochondrial outer membrane and trigger caspase activation. Through this role, PUMA links diverse stress signals to programmed cell death and contributes to tumor suppression, making it an important target in cancer research, apoptosis studies, and investigations of treatment resistance.

Product Description & Applications

The Human PUMA shRNA Lentivirus delivers validated short hairpin RNA targeting BBC3 from a third-generation, self-inactivating lentiviral backbone, with shRNA expression driven by a U6 promoter and a co-expressed fluorescent reporter (GFP or RFP) and antibiotic selection marker. VSV-G pseudotyping supports broad tropism, including primary, suspension, and cryopreserved cells. Each shRNA is validated to achieve at least 70% PUMA knockdown using a fluorescence-based assay.

The high-titer particles are ultra-purified by PEG precipitation and sucrose gradient centrifugation. A shRNA set option provides a mix of two independent validated shRNAs plus a scrambled control. Applications include loss-of-function studies of apoptosis, tumor suppression, and stress responses, and generation of stable knockdown cell lines.

About This Product

This validated shRNA lentivirus targeting BBC3 (NCBI Accession: NM_014417.5) delivers a 19–20 bp shRNA from a third-generation, self-inactivating lentiviral backbone. Expression is driven from a U6 Pol III promoter, with a constitutively expressed fluorescent reporter (GFP, RFP, GFP/Luc, RFP/Luc) and antibiotic selection marker (Blasticidin, Puromycin) co-expressed from the same vector. VSV-G pseudotyping enables broad cell tropism, including primary, suspension, and cryopreserved cell types.

Knockdown is validated using a proprietary bicistronic fluorescence assay in which the target mRNA is co-expressed fused to RFP alongside the shRNA-GFP construct. At least 70% reduction in RFP signal in GFP-positive cells confirms on-target activity — a more direct functional readout than transcript-level qPCR. Polyclonal stable lines can be generated by antibiotic selection within 10 days, preserving parental cell heterogeneity compared to single-clone CRISPR approaches.

What knockdown efficiency does this shRNA lentivirus achieve?
How was the shRNA construct validated?
What reporter and selection marker options are available?
What cell types are recommended for transduction?
Is a negative control lentivirus available?

Can't find the lentiviral construct you need, or want to adjust key design elements? Contact us to discuss custom LV design and optional add-ons.

Common customization requests

  • Insert / payload: replace the gene/sequence, swap to a different isoform, add mutations, or optimize cloning features.
  • Expression design: change promoter (e.g., CMV/EF1α/PGK), add enhancers, or adjust regulatory elements.
  • Reporters: add/swap GFP/RFP/mCherry/luciferase (single or dual reporters where applicable).
  • Selection markers: add/swap puromycin/blasticidin/neomycin or fluorescent selection options.
  • Vector format: switch between OE, shRNA, CRISPR (sgRNA/Cas systems), or control vectors (where supported).

Add-ons you can request

  • Control viruses: empty vector, non-targeting shRNA, reporter-only controls, or matched backbone controls.
  • Packaging / format: concentration options, aliquoting, or custom fill volume for screening workflows.
  • Documentation: construct map/sequence confirmation package (as available) and batch documentation.

What to include in your request

  • Target cell type/model (cell line or primary cells) and intended readout (reporter, knockdown, OE, etc.)
  • Insert sequence (FASTA) or reference ID, plus any required tags/mutations
  • Promoter, reporter, and selection marker preferences
  • Desired scale and preferred format (aliquots / concentration requests)

Email us at support@biohippo.com or use the Talk to a Scientist request form.

Get a Quote

Please use this form for bulk quantity requests or customized products.

Contact Information

Product Information

Try Celltrypse Free – Request Your Sample Today

Experience the power of Celltrypse™, c-LEcta's innovative enzyme solution for gentle and efficient cell dissociation. Request your free sample and discover a superior alternative for your cell culture workflows.

Try Celltrypse Free – Request Your Sample Today

Try Celltrypse Free – Request Your Sample Today

Experience the power of Celltrypse™, c-LEcta's innovative enzyme solution for gentle and efficient cell dissociation. Request your free sample and discover a superior alternative for your cell culture workflows.

Try Celltrypse Free – Request Your Sample Today